Virbac SA Cash Flow Conversion Efficiency
Virbac SA cash flow conversion efficiency. Based on the latest financial reports, Virbac SA (VIRP) has a cash flow conversion efficiency ratio of 0.023x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€24.89 Million ≈ $29.09 Million USD) by net assets (€1.07 Billion ≈ $1.25 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Virbac SA (2002–2024)
Cash flow conversion efficiency of Virbac SA from 2002 to 2024. This chart illustrates how Virbac SA's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Virbac SA stock price for real-time trading data and today's change.
Virbac SA Cash Flow Conversion Ratio Explained
Virbac SA cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Virbac SA Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Virbac SA ranked by their cash flow conversion efficiency. Also see Virbac SA (VIRP) total market value for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
SSAB AB (publ)
ST:SSAB-A
|
0.005x |
|
AIR CHINA LTD H ADR/20
F:AD2B
|
N/A |
|
National Storage REIT
AU:NSR
|
0.018x |
|
Xiangcai Co Ltd
SHG:600095
|
-0.002x |
|
China South Publishing & Media Group Co Ltd
SHG:601098
|
-0.022x |
|
Vidrala SA
MC:VID
|
0.048x |
|
Ondas Holdings Inc.
NASDAQ:ONDS
|
-0.055x |
|
Gerdau S.A
SA:GGBR3
|
0.028x |
Annual Cash Flow Conversion Efficiency for Virbac SA (2002–2024)
The table below shows the annual cash flow conversion efficiency of Virbac SA from 2002 to 2024. Review cash generation quality of Virbac SA to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | €1.04 Billion ≈ $1.22 Billion |
€204.22 Million ≈ $238.76 Million |
0.196x | +49.71% |
| 2023-12-31 | €909.92 Million ≈ $1.06 Billion |
€118.96 Million ≈ $139.07 Million |
0.131x | +10.81% |
| 2022-12-31 | €838.98 Million ≈ $980.86 Million |
€98.98 Million ≈ $115.72 Million |
0.118x | -34.14% |
| 2021-12-31 | €725.19 Million ≈ $847.82 Million |
€129.90 Million ≈ $151.87 Million |
0.179x | -1.30% |
| 2020-12-31 | €655.22 Million ≈ $766.02 Million |
€118.92 Million ≈ $139.03 Million |
0.181x | -23.89% |
| 2019-12-31 | €551.88 Million ≈ $645.20 Million |
€131.61 Million ≈ $153.86 Million |
0.238x | +41.41% |
| 2018-12-31 | €495.87 Million ≈ $579.73 Million |
€83.62 Million ≈ $97.76 Million |
0.169x | -25.10% |
| 2017-12-31 | €478.82 Million ≈ $559.79 Million |
€107.81 Million ≈ $126.04 Million |
0.225x | -17.69% |
| 2016-12-31 | €520.79 Million ≈ $608.85 Million |
€142.45 Million ≈ $166.54 Million |
0.274x | +185.41% |
| 2015-12-31 | €482.29 Million ≈ $563.85 Million |
€46.22 Million ≈ $54.04 Million |
0.096x | -39.55% |
| 2014-12-31 | €482.19 Million ≈ $563.73 Million |
€76.45 Million ≈ $89.37 Million |
0.159x | -10.78% |
| 2013-12-31 | €414.37 Million ≈ $484.45 Million |
€73.63 Million ≈ $86.08 Million |
0.178x | -27.04% |
| 2012-12-31 | €398.42 Million ≈ $465.79 Million |
€97.03 Million ≈ $113.44 Million |
0.244x | +23.73% |
| 2011-12-31 | €313.87 Million ≈ $366.94 Million |
€61.78 Million ≈ $72.23 Million |
0.197x | -29.06% |
| 2010-12-31 | €302.35 Million ≈ $353.48 Million |
€83.90 Million ≈ $98.08 Million |
0.277x | +1.18% |
| 2009-12-31 | €236.20 Million ≈ $276.14 Million |
€64.78 Million ≈ $75.73 Million |
0.274x | +30.39% |
| 2008-12-31 | €201.01 Million ≈ $235.01 Million |
€42.28 Million ≈ $49.43 Million |
0.210x | -23.17% |
| 2007-12-31 | €184.28 Million ≈ $215.45 Million |
€50.45 Million ≈ $58.98 Million |
0.274x | -7.49% |
| 2006-12-31 | €164.93 Million ≈ $192.82 Million |
€48.81 Million ≈ $57.06 Million |
0.296x | +32.55% |
| 2005-12-31 | €160.19 Million ≈ $187.28 Million |
€35.76 Million ≈ $41.81 Million |
0.223x | -29.10% |
| 2004-12-31 | €131.17 Million ≈ $153.35 Million |
€41.30 Million ≈ $48.29 Million |
0.315x | +52.97% |
| 2003-12-31 | €129.09 Million ≈ $150.91 Million |
€26.57 Million ≈ $31.07 Million |
0.206x | -11.79% |
| 2002-12-31 | €132.52 Million ≈ $154.93 Million |
€30.92 Million ≈ $36.15 Million |
0.233x | -- |
About Virbac SA
Virbac SA manufactures and sells a range of products and services for companion and farm animals in Europe, North America, Latin America, East Asia, India, Africa, the Middle East, and the Pacific. The company offers a range of vaccines, antibiotics, parasiticides, and anti-inflammatory drugs, as well as dermatology, dental, specialty, diagnosis, nutrition, petfood, and pharmaceutical products. I… Read more